Hsu Shao-Yun, Cheng Hsu-Tang, Manrique Oscar, Hsu Yung-Chang
Department of Plastic Surgery, China Medical University Hospital, Taichung, Taiwan.
Medicine (Baltimore). 2017 Oct;96(41):e7932. doi: 10.1097/MD.0000000000007932.
A 54-year-old Taiwanese male came to our hospital presented with right retromolar mucoepidermoid carcinoma. Composite resection and right modified radical neck dissection were performed. We then use free anteral lateral thigh flap to reconstruct the defect. However, venous congestion was found 32 h after the surgery.
The main concerns of the patient is complete salvage of the free flap, and avoiding the secondary free flap harvesting and reconstruction surgeries.
Right retromolar mucoepidermoid carcinoma.
We report the case of a patient with an anterolateral thigh flap with venous perianastomosis thrombosis and intraflap microvascular thrombosis successfully salvaged using anterograde intra-arterial injection of low-dose urokinase (60,000 U), without administering intravenous anticoagulation heparin during the postoperative period.
The flap was completely salvaged 3 days after treatment. No other flap-associated or bleeding complications were noted. The intra-oral wounds around the flap completely healed without any post-ischemic complications.
Although the ideal urokinase doses and delivery procedures for free flap salvage have not been developed thus far, our method maximizes the urokinase gradient in the flap, minimizes the total dose required for flap salvage, and ensures no systemic spread. Thus, compared with other thrombolytic agents, urokinase may be more effective and safe for free flap salvage. With more experience, a standardized dosage and procedure can be developed.
一名54岁的台湾男性因右磨牙后区黏液表皮样癌前来我院就诊。进行了联合切除术和右侧改良根治性颈清扫术。然后我们使用游离股前外侧皮瓣修复缺损。然而,术后32小时发现皮瓣静脉淤血。
患者主要关注的是游离皮瓣的完全挽救,避免二次游离皮瓣切取和重建手术。
右磨牙后区黏液表皮样癌。
我们报告了一例股前外侧皮瓣患者,其吻合口周围静脉血栓形成和皮瓣内微血管血栓形成,通过顺行动脉内注射低剂量尿激酶(60,000 U)成功挽救,术后未给予静脉抗凝肝素。
治疗3天后皮瓣完全挽救。未发现其他与皮瓣相关的或出血并发症。皮瓣周围的口腔内伤口完全愈合,无任何缺血后并发症。
尽管目前尚未确定游离皮瓣挽救的理想尿激酶剂量和给药程序,但我们的方法使皮瓣中的尿激酶梯度最大化,使皮瓣挽救所需的总剂量最小化,并确保无全身扩散。因此,与其他溶栓药物相比,尿激酶在游离皮瓣挽救方面可能更有效、更安全。随着经验的增加,可以制定标准化的剂量和程序。